Why use an immune library instead of a naive library for Porcine (Pig) Monoclonal Antibody Discovery?

An immune antibody library is generated from an animal that has been exposed to the target antigen. This results in a library "enriched" with high-affinity B-cells that have undergone in vivo affinity maturation. Consequently, screening an immune library usually yields antibodies with significantly higher affinity and specificity than those derived from a naive library.

How do you ensure the diversity of the immune antibody library?

Diversity is ensured at multiple levels: starting with a large population of harvested B-cells, using optimized PCR primers to capture all variable gene families, and maintaining a high transformation efficiency during library construction to reach a size of at least 10^9 clones.

Can you produce full-length porcine IgG after screening?

Yes. Once we identify the best scFv or Fab candidates through phage display, we can sequence the clones and perform recombinant expression in mammalian cells (e.g., CHO or HEK293) to produce full-length, glycosylated Porcine (Pig) Monoclonal Antibody.

What is the typical success rate for difficult targets like transmembrane proteins?

For challenging targets, we utilize specialized panning strategies such as cell-based panning or the use of Proteoliposomes/Nanodiscs. Our success rate for these complex antigens is among the highest in the industry thanks to our multi-pronged screening approach.

Is the sequence information provided to the client?

Absolutely. Upon completion of the project, we provide the full sequence information of the positive clones along with the purification and characterization data.

Advanced Porcine (Pig) Monoclonal Antibody Discovery Service

Background Technology Workflow Advanced Strategy Advantage Related Services FAQ Online Inquiry

In the rapidly evolving landscape of veterinary medicine and translational immunology, the demand for high-quality Porcine (Pig) Monoclonal Antibody Discovery has reached an all-time high. As an industry leader with over 20 years of experience, Creative Biolabs provides a world-class platform dedicated to the development of porcine antibodies. By leveraging our proprietary platform, we specialize in the construction and screening of immune antibody library systems to deliver monoclonal antibodies with unparalleled specificity and affinity. Our services are designed to support researchers in agricultural science, vaccine development, and xenotransplantation. Through our phage display-based Porcine (Pig) Monoclonal Antibody discovery technology, we bypass the limitations of traditional hybridoma methods, offering a faster and more robust route to antibody generation.

Discuss Your Project Today

The Strategic Importance of Porcine (Pig) Monoclonal Antibody Discovery

The pig (Sus scrofa) is not only a vital livestock species but also a critical model organism for human disease research. Due to their physiological and anatomical similarities to humans, pigs are the primary candidates for xenotransplantation and the study of infectious diseases such as Swine Flu (H1N1) and African Swine Fever (ASF).

Generating a high-quality Porcine (Pig) Monoclonal Antibody is essential for:

Veterinary Diagnostics: Developing rapid assays for porcine pathogens.
Vaccine Research: Mapping epitopes and assessing neutralizing responses.
Xenotransplantation: Targeting porcine-specific antigens to reduce transplant rejection.
Basic Immunology: Characterizing the porcine immune system at the molecular level.

Fig. 1 IFA testing the neutralizing activity of porcine mAbs (mAb1, mAb9, mAb11) against CSFVs.¹

Phage Display: The Gold Standard for Porcine Antibody Discovery

While hybridoma technology has been the traditional route, it often faces challenges with pig cells due to the lack of stable porcine myeloma fusion partners. Creative Biolabs overcomes these hurdles using phage display, a powerful in vitro selection technique.

Advantages of Phage Display-based Porcine (Pig) Monoclonal Antibody Discovery

Compared to traditional methods, our phage display platform offers:

Wider Diversity: Capacity to generate libraries containing 10⁸ to 10¹¹ unique clones.
High Affinity: Selection under stringent conditions ensures the isolation of high-affinity binders.
Flexibility: Antibodies can be formatted as scFv, Fab, or full-length IgG.
Speed: The biopanning process is significantly faster than the months required for hybridoma stability testing.

Comprehensive Workflow: Construction and Screening of Immune Antibody Library

The core of our Porcine (Pig) Monoclonal Antibody Discovery service lies in the meticulous construction and screening of immune antibody library protocols. We follow a highly optimized pipeline to ensure the success of your project.

1. Strategic Immunization

We utilize optimized immunization protocols in various pig breeds (e.g., Landrace, Yorkshire, or Mini-pigs). Our experts design the immunization schedule to maximize the B-cell response against your specific target.

Antigen Types: Small molecules, recombinant proteins, whole cells, or DNA vaccines.
Adjuvant Selection: Custom blends to trigger robust IgG production.

2. RNA Extraction and cDNA Synthesis

Once a high serum titer is confirmed, we harvest PBMCs or lymphoid tissues (spleen/lymph nodes). Total RNA is extracted and reverse-transcribed into cDNA, preserving the diverse repertoire of the porcine immune response.

3. PCR Amplification of Porcine V-Genes

Using a comprehensive set of proprietary primers, we amplify the VH and VL (kappa and lambda) gene repertoires. This step is critical for maintaining the natural diversity of the immune antibody library for Porcine (Pig) Monoclonal Antibody.

4. Library Construction

The amplified variable regions are cloned into our advanced phagemid vectors. We typically produce two formats:

scFv (Single-chain Variable Fragment): VH and VL joined by a flexible linker.
Fab (Fragment Antigen-Binding): Consisting of the entire light chain and the VH-CH1 fragment of the heavy chain.

5. Biopanning and Screening

This is the most crucial phase of phage display-based Porcine (Pig) Monoclonal Antibody discovery. We employ several panning strategies:

Solid-phase Panning: Antigen immobilized on immunotubes or plates.
Liquid-phase Panning: Using biotinylated antigens and streptavidin beads to preserve native protein conformation.
Cell-based Panning: For targets like GPCRs or ion channels that require a membrane environment.

Advanced Strategies in Porcine Antibody Engineering

As a leader in the field, we incorporate the latest biotechnological trends into our Porcine (Pig) Monoclonal Antibody Discovery pipeline.

Next-Generation Sequencing (NGS) Integration

By combining phage display with NGS, we analyze the entire immune antibody library after each round of panning. This allows us to identify high-affinity clones that might be lost during traditional colony screening, ensuring no potent binder is overlooked.

Species-Specific Tailoring

Pigs have a unique immunoglobulin repertoire compared to rodents or humans. Our specialists understand the nuances of porcine IgG subclasses (IgG1, IgG2, IgG3, IgG4) and ensure that the final Porcine (Pig) Monoclonal Antibody exhibits the desired effector functions.

Why Choose Creative Biolabs?

At Creative Biolabs, we are dedicated to pushing the boundaries of Porcine (Pig) Monoclonal Antibody Discovery. Whether you are working on a novel vaccine or exploring the frontiers of xenotransplantation, our phage display-based Porcine (Pig) Monoclonal Antibody platform offers the precision and reliability you need. By choosing our construction and screening of immune antibody library services, you are partnering with a team of experts who prioritize scientific excellence and client success. Our streamlined workflow, from immunization to recombinant production, ensures that you receive the highest quality antibodies tailored to your specific research needs.

20+ Years of Expertise: We have successfully completed thousands of antibody discovery projects.
Proprietary Primer Sets: Our primers for porcine V-gene amplification are the most comprehensive in the industry.
State-of-the-Art Facilities: Equipped with high-throughput liquid handling and NGS platforms.
Global Recognition: Trusted by top pharmaceutical companies and academic institutions worldwide.

Explore Our Comprehensive Services

While our phage display immune antibody library platform is a powerful engine, we offer a comprehensive suite of discovery technologies to ensure we always use the right tool for the job. Our Monoclonal Antibody Generation from Various Immunized Antibody Libraries Services:

Contact Us Today Ready to start your Porcine (Pig) Monoclonal Antibody project? Contact our scientists for a detailed consultation and a customized quote. Let Creative Biolabs be the engine behind your next biological breakthrough.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: Why use an immune library instead of a naive library for Porcine (Pig) Monoclonal Antibody Discovery?
A: An immune antibody library is generated from an animal that has been exposed to the target antigen. This results in a library "enriched" with high-affinity B-cells that have undergone in vivo affinity maturation. Consequently, screening an immune library usually yields antibodies with significantly higher affinity and specificity than those derived from a naive library.
Q: How do you ensure the diversity of the immune antibody library?
A: Diversity is ensured at multiple levels: starting with a large population of harvested B-cells, using optimized PCR primers to capture all variable gene families, and maintaining a high transformation efficiency during library construction to reach a size of at least 10⁹ clones.
Q: Can you produce full-length porcine IgG after screening?
A: Yes. Once we identify the best scFv or Fab candidates through phage display, we can sequence the clones and perform recombinant expression in mammalian cells (e.g., CHO or HEK293) to produce full-length, glycosylated Porcine (Pig) Monoclonal Antibody.
Q: What is the typical success rate for difficult targets like transmembrane proteins?
A: For challenging targets, we utilize specialized panning strategies such as cell-based panning or the use of Proteoliposomes/Nanodiscs. Our success rate for these complex antigens is among the highest in the industry thanks to our multi-pronged screening approach.
Q: Is the sequence information provided to the client?
A: Absolutely. Upon completion of the project, we provide the full sequence information of the positive clones along with the purification and characterization data.

Reference

Wang, Lihua, et al. "Development of porcine monoclonal antibodies with in vitro neutralizing activity against classical swine fever virus from C-strain E2-specific single B cells." Viruses 15.4 (2023): 863. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/v15040863

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.